Overview :
OneSCD is a global partnership for better Sickle Cell Disease care. Learn its host, partners, objectives, SCD causes, symptoms and treatment in simple English.
OneSCD: Global Partnership
India recently co-hosted the launch of OneSCD in New York. The launch took place on the sidelines of the 81st session of the United Nations General Assembly (UNGA 81) . OneSCD aims to improve care and reduce gaps in Sickle Cell Disease treatment.
What Is OneSCD?
OneSCD is a global partnership for better and more equal Sickle Cell Disease care. It works as a coordination platform. It supports existing country-led SCD programmes. It also helps countries expand proven methods of care.
Who Hosted OneSCD?
The Government of Nigeria hosted OneSCD. UNICEF, WHO, Africa CDC, the World Coalition on Sickle Cell Disease and St. Jude Children’s Research Hospital co-organised the initiative.
The partnership brings together governments, UN agencies, health experts, civil society groups and people living with Sickle Cell Disease.
Main Focus of OneSCD
OneSCD focuses on international cooperation. It aims to improve access to prevention, diagnosis, treatment and long-term care . The partnership also supports stronger national programmes for Sickle Cell Disease.
What Is Sickle Cell Disease?
Sickle Cell Disease is a group of inherited blood disorders . It affects haemoglobin. Haemoglobin is a protein in red blood cells that carries oxygen around the body.
The most common and severe form is sickle cell anaemia .
How Does SCD Affect Blood Flow?
Normally, red blood cells have a round, flexible shape. They can move easily through blood vessels. In SCD, abnormal haemoglobin called haemoglobin S can change the cells into a sickle or crescent shape.
These cells do not move easily. They can block blood vessels and slow blood flow. This can cause pain and other health problems.
Cause and Symptoms
A defective sickle cell gene causes Sickle Cell Disease. Symptoms often start in early childhood. Early signs can include extreme tiredness, swollen hands and feet and jaundice.
Later, patients may face severe pain, anaemia, organ damage and infections.
Treatment
A bone marrow transplant , also called a stem cell transplant, can cure Sickle Cell Disease in some cases. Scientists are also exploring gene therapy as another possible treatment.
Why OneSCD Matters
Sickle Cell Disease needs long-term care. Many patients need regular diagnosis, treatment and medical support. OneSCD aims to help countries work together and improve access to care.
For India, such health partnerships also matter for public health programmes and medical innovation. New health technologies can support better diagnosis and treatment, just as agricultural innovation supports better farming and the Indian startup ecosystem develops new solutions.
Exam-Focused Points :
- OneSCD: A global partnership to advance equity and improve Sickle Cell Disease care.
- Launch: India co-hosted its launch in New York during UNGA 81 .
- Host: Government of the Federal Republic of Nigeria .
- Co-organisers: UNICEF, WHO, Africa CDC, World Coalition on Sickle Cell Disease and St. Jude Children’s Research Hospital.
- SCD: An inherited group of blood disorders that affects haemoglobin.
- Most common and severe type: Sickle cell anaemia .
- Treatment: Bone marrow or stem cell transplant can cure SCD in some cases; gene therapy is also being explored.
FAQs :
1. What is OneSCD?
OneSCD is a global partnership to improve Sickle Cell Disease care.
2. Which country hosted OneSCD?
Nigeria hosted OneSCD.
3. What is Sickle Cell Disease?
It is a group of inherited blood disorders that affects haemoglobin.
4. What is sickle cell anaemia?
It is the most common and severe type of Sickle Cell Disease.
5. What can cause SCD?
A defective sickle cell gene causes Sickle Cell Disease.